Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2025-12-24 @ 5:21 PM
NCT ID:
NCT06813950
Eligibility Criteria:
Inclusion Criteria:
* 1\. Age range: Participants must be between 8 and 18 years old at the start of the study.
2\. Residency: Patients residing within the city limits of Quito, Ecuador. 3. Treatment status:
• Patients are being evaluated or treated at Hospitals SOLCA and Baca Ortiz.
* Patients are either currently undergoing active treatment for pediatric malignancies, or
* Patients are in the post-treatment phase after a pediatric cancer diagnosis.
* The volunteer or a family member that lives with the possible participant has a cellphone so the survey can be administered and answered.
Exclusion Criteria:
* 1\. The presence of a malignant solid tumor which has not yet been surgically addressed.
2\. A psychiatric diagnosis of cognitive impairment. 3. A diagnosis of osteosarcoma. 4. A history of cardiac pathology. 5. The patient is in the pediatric inpatient ward or was one month prior to the enrollment phase.
6\. The patient is stationed at the pediatric intensive care unit. 7. The patient received high-dose chemotherapy with methotrexate greater than 1000 mg/m2/dose or cytarabine greater than 1 g/m2/dose in the last month.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
18 Years
Study:
NCT06813950
Study Brief:
Protocol Section:
NCT06813950